Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib.

Salivary Gland Secretory Carcinoma With High-Grade Transformation, CDKN2A/B Loss, Distant Metastasis, and Lack of Sustained Response to Crizotinib. Int J Surg Pathol. 2017 Oct; 25(7):613-618.

View in: PubMed

subject areas

Adenocarcinoma, Clear Cell
Adult
Antineoplastic Combined Chemotherapy Protocols
Cyclin-Dependent Kinase Inhibitor p15
Cyclin-Dependent Kinase Inhibitor p16
Cyclin-Dependent Kinase Inhibitor p18
Diagnosis, Differential
Disease Progression
Drug Resistance, Neoplasm
Fatal Outcome
Gene Rearrangement
Humans
Immunohistochemistry
Magnetic Resonance Imaging
Male
Mammary Analogue Secretory Carcinoma
Myoepithelioma
Oncogene Proteins, Fusion
Parotid Gland
Pleural Neoplasms
Pyrazoles
Pyridines
Salivary Gland Neoplasms
Translocation, Genetic
Treatment Outcome

authors with profiles

Nicole A. Cipriani
Christopher M Straus
Elizabeth Blair
Daniel T. Ginat